Lupin and Sun settle Bromsite patent suit after ruling

10-02-2022

Alex Baldwin

Lupin and Sun settle Bromsite patent suit after ruling

rafapress / Shutterstock.com

Sun Pharmaceuticals and Lupin Pharmaceuticals have decided to settle a patent suit related to Sun’s Bromsite (bromfenac) eye drops, invalidating an opinion handed down by the US District Court for the District of New Jersey in September.


Lupin Pharmaceuticals, Lupin, generics

LSIPR